Lactoferrin, a bird's eye view

Biochemistry and Cell Biology

Volumn 90, Issue 3, 2012, Pages 233-244

  Vogel, Hans J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anticancer; Antimicrobial; Endotoxin; Immuno modulator; Iron binding protein; Transcription factor

Indexed keywords

ANTICANCER; ANTIMICROBIAL; ENDOTOXIN; IMMUNO-MODULATOR; IRON-BINDING PROTEIN;

BINDING ENERGY; MAMMALS; TRANSCRIPTION FACTORS;

IRON;

BIOLOGICAL MARKER; CYTOKINE; DELTA LACTOFERRIN; GLYCOPROTEIN; IRON; LACTOFERRICIN; LACTOFERRIN; LIPOPOLYSACCHARIDE; PLACEBO; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; BONE GROWTH; CHRONIC PERIODONTITIS; CRYSTAL STRUCTURE; ENTERITIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IRON BINDING CAPACITY; LUNG NON SMALL CELL CANCER; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NONHUMAN; OSSIFICATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; TRANSCRIPTION REGULATION; WOUND HEALING;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BINDING SITES; HUMANS; IMMUNOLOGIC FACTORS; IRON; LACTOFERRIN; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SURFACE PROPERTIES;

AVES; BOVINAE;

EID: 84861361791     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o2012-016     Document Type: Article

References (122)

1. Amulic B. Cazalet C. Hayes G.L. Metzler K.D. Zychlinsky A. 2012. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30 (1): 459-489. 10.1146/annurev-immunol-020711-074942 22224774
2. Anderson B.F. Baker H.M. Dodson E.J. Norris G.E. Rumball S.V. Waters J.M. Baker E.N. 1987. Structure of human lactoferrin at 3.2-A resolution. Proc. Natl. Acad. Sci. U.S.A. 84 (7): 1769-1773. 10.1073/pnas.84.7.1769 3470756
3. Andrä J. Lohner K. Blondelle S.E. Jerala R. Moriyon I. Koch M.H.J. et al. 2005. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide. Biochem. J. 385 (1): 135 - 143. 10.1042/BJ20041270 15344905
4. Appelmelk B.J. An Y.Q. Geerts M. Thijs B.G. de Boer H.A. MacLaren D.M. et al. 1994. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62 (6): 2628-2632. 8188389
5. Arnold R.R. Cole M.F. McGhee J.R. 1977. A bactericidal effect for human lactoferrin. Science, 197 (4300): 263-265. 10.1126/science.327545 327545
6. Artym J. Zimecki M. 2007. The effects of lactoferrin on myelopoiesis: can we resolve the controversy? Postepy Hig. Med. Dosw. (Online), 61: 129-150. 17410054
7. Ashby B. Garrett Q. Willcox M. 2011. Bovine lactoferrin structures promoting corneal epithelial wound healing in vitro. Invest. Ophthalmol. Vis. Sci. 52 (5): 2719-2726. 10.1167/iovs.10-6352 21282581
8. Bailey S. Evans R.W. Garratt R.C. Gorinsky B. Hasnain S. Horsburgh C. et al. 1988. Molecular structure of serum transferrin at 3.3-A resolution. Biochemistry, 27 (15): 5804-5812. 10.1021/bi00415a061 3179277
9. Baker H.M. Baker E.N. 2004. Lactoferrin and iron: structural and dynamic aspects of binding and release. Biometals, 17 (3): 209-216. 10.1023/B:BIOM. 0000027694.40260.70 15222467
10. Baker H.M. Baker E.N. 2012. A structural perspective on lactoferrin function. Biochem. Cell Biol.,. This issue. 10.1139/o11-071 22292559
11. Beddek A.J. Schryvers A.B. 2010. The lactoferrin receptor complex in Gram negative bacteria. Biometals, 23 (3): 377-386. 10.1007/s10534-010-9299-z 20155302
12. Bellamy W. Takase M. Yamauchi K. Wakabayashi H. Kawase K. Tomita M. 1992. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta, 1121 (1-2): 130-136. 10.1016/0167-4838(92)90346-F 1599934
13. Beniwal P. Harrell L. 2010. The status of diagnostic markers for inflammatory bowel disease. Curr. Gastroenterol. Rep. 12 (6): 479-484. 10.1007/s11894-010-0145-9 20890737
14. Berkhout B. Floris R. Recio I. Visser S. 2004. The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1. Biometals, 17 (3): 291-294. 10.1023/B:BIOM.0000027707.82911.be 15222480
15. Berlutti F. Pantanella F. Natalizi T. Frioni A. Paesano R. Polimeni A. Valenti P. 2011. Antiviral properties of lactoferrin- A natural immunity molecule. Molecules, 16 (8): 6992-7018. 10.3390/molecules16086992 21847071
16. Beutler B. 2002. LPS in microbial pathogenesis: promise and fulfilment. J. Endotoxin Res. 8 (5): 329-335. 12537691
17. Beutler B. Moresco E.M. 2008. The forward genetic dissection of afferent innate immunity. Curr. Top. Microbiol. Immunol. 321: 3-26. 10.1007/978-3-540- 75203-5-1 18727485
18. Bharadwaj S. Naidu A.G. Betageri G.V. Prasadarao N.V. Naidu A.S. 2009. Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women. Osteoporos. Int. 20 (9): 1603-1611. 10.1007/s00198-009-0839-8 19172341
19. Bharadwaj S. Naidu T.A. Betageri G.V. Prasadarao N.V. Naidu A.S. 2010. Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women. Inflamm. Res. 59 (11): 971-978. 10.1007/s00011-010-0211-7 20473630
20. Blais A. Malet A. Mikogami T. Martin-Rouas C. Tome D. 2009. Oral bovine lactoferrin improves bone status of ovariectomized mice. Am. J. Physiol. Endocrinol. Metab. 296 (6): E1281-E1288. 10.1152/ajpendo.90938.2008 19336659
21. Bolscher J. Nazmi K. van Marle J. van 't Hof W. Veerman E. 2012. Chimerization of lactoferricin and lactoferrampin peptides strongly potentiates the killing activity against Candida albicans. Biochem. Cell Biol. This issue. 10.1139/o11-085 22364313
22. Borregaard N. Sorensen O.E. Theilgaard-Monch K. 2007. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 28 (8): 340-345. 10.1016/j.it.2007.06.002 17627888
23. Brinkmann V. Zychlinsky A. 2007. Beneficial suicide: why neutrophils die to make NETs. Nat. Rev. Microbiol. 5 (8): 577-582. 10.1038/nrmicro1710 17632569
24. Brouwer C.P. Rahman M. Welling M.M. 2011. Discovery and development of a synthetic peptide derived from lactoferrin for clinical use. Peptides, 32 (9): 1953-1963. 10.1016/j.peptides.2011.07.017 21827807
25. Caccavo D. Sebastiani G.D. Di Monaco C. Guido F. Galeazzi M. Ferri G.M. et al. 1999. Increased levels of lactoferrin in synovial fluid but not in serum from patients with rheumatoid arthritis. Int. J. Clin. Lab. Res. 29 (1): 30-35. 10.1007/s005990050059 10356661
26. Calmettes C. Alcantara J. Yu R.H. Schryvers A.B. Moraes T.F. 2012. The structural basis of transferrin sequestration by transferrin-binding protein B. Nat. Struct. Mol. Biol. 19 (3): 358-360. 10.1038/nsmb.2251 22343719
27. Cheng Y. Zak O. Aisen P. Harrison S.C. Walz T. 2004. Structure of the human transferrin receptor-transferrin complex. Cell, 116 (4): 565-576. 10.1016/S0092-8674(04)00130-8 14980223
28. Chu B.C. Garcia-Herrero A. Johanson T.H. Krewulak K.D. Lau C.K. Peacock R.S. et al. 2010. Siderophore uptake in bacteria and the battle for iron with the host; a bird's eye view. Biometals, 23 (4): 601-611. 10.1007/s10534-010- 9361-x 20596754
29. Clark S.R. Ma A.C. Tavener S.A. McDonald B. Goodarzi Z. Kelly M.M. et al. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13 (4): 463-469. 10.1038/nm1565 17384648
30. Cornish J. Callon K.E. Naot D. Palmano K.P. Banovic T. Bava U. et al. 2004. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology, 145 (9): 4366-4374. 10.1210/en.2003-1307 15166119
31. Crichton, R.R. 2009. Iron Metabolism: From Molecular Mechanisms to Clinical Consequences. John Wiley & Sons Ltd., Chichester, West Sussex.
32. Dave M. Loftus E.V. Jr. 2012. Mucosal healing in inflammatory bowel disease- A true paradigm of success? Gastroenterol. Hepatol. (N.Y.), 8 (1): 29-38. 22347830
33. Davidson L.A. Lonnerdal B. 1988. Specific binding of lactoferrin to brush-border membrane: ontogeny and effect of glycan chain. Am. J. Physiol. 254 (4): G580-G585. 2833117
34. de la Rosa G. Yang D. Tewary P. Varadhachary A. Oppenheim J.J. 2008. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J. Immunol. 180 (10): 6868-6876. 18453607
35. Deshayes S. Morris M.C. Divita G. Heitz F. 2005. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci. 62 (16): 1839-1849. 10.1007/s00018-005-5109-0 15968462
36. Digumarti R. Wang Y. Raman G. Doval D.C. Advani S.H. Julka P.K. et al. 2011. A randomized, double-blind, placebo-controlled, phase II study of oral talactoferrin in combination with carboplatin and paclitaxel in previously untreated locally advanced or metastatic non-small cell lung cancer. J. Thorac. Oncol. 6 (6): 1098-1103. 10.1097/JTO.0b013e3182156250 21532506
37. Dijkshoorn L. Brouwer C.P. Bogaards S.J. Nemec A. van den Broek P.J. Nibbering P.H. 2004. The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 48 (12): 4919-4921. 10.1128/AAC.48.12.4919-4921.2004 15561882
38. Duchardt F. Ruttekolk I.R. Verdurmen W.P. Lortat-Jacob H. Burck J. Hufnagel H. et al. 2009. A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. J. Biol. Chem. 284 (52): 36099-36108. 10.1074/jbc.M109.036426 19858187
39. El Yazidi-Belkoura I. Legrand D. Nuijens J. Slomianny M.C. van Berkel P. Spik G. 2001. The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus. Biochim. Biophys. Acta, 1568 (3): 197-204. 10.1016/S0304- 4165(01)00222-7 11786226
40. Elass-Rochard E. Roseanu A. Legrand D. Trif M. Salmon V. Motas C. et al. 1995. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312 (3): 839-845. 8554529
41. Eliassen L.T. Berge G. Leknessund A. Wikman M. Lindin I. Lokke C. et al. 2006. The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. Int. J. Cancer, 119 (3): 493-500. 10.1002/ijc.21886 16572423
42. Engelmayer J. Blezinger P. Varadhachary A. 2008. Talactoferrin stimulates wound healing with modulation of inflammation. J. Surg. Res. 149 (2): 278-286. 10.1016/j.jss.2007.12.754 18619616
43. Ganz T. Nemeth E. 2012. Hepcidin and iron homeostasis. Biochim. Biophys. Acta,. In press. 10.1016/j.bbamcr.2012.01.014 22306005
44. Giansanti F. Leboffe L. Pitari G. Ippoliti R. Antonini G. 2012. Physiological roles of ovotransferrin. Biochim. Biophys. Acta, 1820 (3): 218-225. 10.1016/j.bbagen.2011.08.004 21854833
45. Gibbons J.A. Kanwar R.K. Kanwar J.R. 2011. Lactoferrin and cancer in different cancer models. Front. Biosci. (Schol. Ed.), 3 (1): 1080-1088. 10.2741/212 21622257
46. Gifford J.L. Hunter H.N. Vogel H.J. 2005. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 62 (22): 2588-2598. 10.1007/s00018-005-5373-z 16261252
47. Glimvall P. Wickström C. Jansson H. 2012. Elevated levels of salivary lactoferrin, a marker for chronic periodontitis? J. Periodontal Res. In press. 10.1111/j.1600-0765.2012.01479.x 22471324
48. Groves M.L. 1960. The isolation of a red protein from milk. J. Am. Chem. Soc. 82 (13): 3345-3350. 10.1021/ja01498a029
49. Ha C. Kornbluth A. 2010. Mucosal healing in inflammatory bowel disease: where do we stand? Curr. Gastroenterol. Rep. 12 (6): 471-478. 10.1007/s11894-010-0146-8 20886319
50. Haney E.F. Lau F. Vogel H.J. 2007. Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin. Biochim. Biophys. Acta, 1768 (10): 2355-2364. 10.1016/j.bbamem. 2007.04.018 17560539
51. Haney E.F. Nazmi K. Lau F. Bolscher J.G. Vogel H.J. 2009. Novel lactoferrampin antimicrobial peptides derived from human lactoferrin. Biochimie, 91 (1): 141-154. 10.1016/j.biochi.2008.04.013 18534196
52. Haney E.F. Nazmi K. Bolscher J.G. Vogel H.J. 2012. Structural and biophysical characterization of an antimicrobial peptide chimera comprised of lactoferricin and lactoferrampin. Biochim. Biophys. Acta, 1818 (3): 762-775. 10.1016/j.bbamem.2011.11.023 22155682
53. Haug B.E. Strom M.B. Svendsen J.S. 2007. The medicinal chemistry of short lactoferricin-based antibacterial peptides. Curr. Med. Chem. 14 (1): 1-18. 10.2174/092986707779313435 17266565
54. He J. Furmanski P. 1995. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature, 373 (6516): 721-724. 10.1038/373721a0 7854459
55. Hu W. Zhao J. Wang J. Yu T. Wang J. Li N. 2012. Transgenic milk containing recombinant human lactoferrin modulates the intestinal flora in piglets. Biochem. Cell Biol. This issue. 10.1139/o2012-003 22400985
56. Hunter H.N. Demcoe A.R. Jenssen H. Gutteberg T.J. Vogel H.J. 2005. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob. Agents Chemother. 49 (8): 3387-3395. 10.1128/AAC.49.8.3387-3395.2005 16048952
57. Hwang P.M. Zhou N. Shan X. Arrowsmith C.H. Vogel H.J. 1998. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry, 37 (12): 4288-4298. 10.1021/bi972323m 9521752
58. Jenssen H. 2005. Anti herpes simplex virus activity of lactoferrin/lactoferricin-an example of antiviral activity of antimicrobial protein/peptide. Cell. Mol. Life Sci. 62 (24): 3002-3013. 10.1007/s00018-005- 5228-7 16261265
59. Jenssen H. 2009. Therapeutic approaches using host defence peptides to tackle herpes virus infections. Viruses, 1 (3): 939-964. 10.3390/v1030939 21994576
60. Jenssen H. Hancock R.E. 2009. Antimicrobial properties of lactoferrin. Biochimie, 91 (1): 19-29. 10.1016/j.biochi.2008.05.015 18573312
61. Johansson B. 1960. Isolation of an iron-containing red protein from human milk. Acta Chem. Scand. 14 (2): 510-512.
62. Kanyshkova T.G. Semenov D.V. Buneva V.N. Nevinsky G.A. 1999. Human milk lactoferrin binds two DNA molecules with different affinities. FEBS Lett. 451 (3): 235-237. 10.1016/S0014-5793(99)00579-7 10371196
63. Klein G. Imreh S. Zabarovsky E.R. 2007. Why do we not all die of cancer at an early age? Adv. Cancer Res. 98: 1-16. 10.1016/S0065-230X(06)98001-4 17433906
64. Kozu T. Iinuma G. Ohashi Y. Saito Y. Akasu T. Saito D. et al. 2009. Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev. Res. (Phila.), 2 (11): 975-983. 10.1158/1940-6207.CAPR-08-0208 19861543
65. Kurokawa H. Mikami B. Hirose M. 1995. Crystal structure of diferric hen ovotransferrin at 2.4 A resolution. J. Mol. Biol. 254 (2): 196-207. 10.1006/jmbi.1995.0611 7490743
66. Kuwata H. Yip T.T. Tomita M. Hutchens T.W. 1998 a. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim. Biophys. Acta, 1429 (1): 129-141. 10.1016/S0167-4838(98)00224-6 9920391
67. Kuwata H. Yip T.T. Yip C.L. Tomita M. Hutchens T.W. 1998 b. Direct detection and quantitative determination of bovine lactoferricin and lactoferrin fragments in human gastric contents by affinity mass spectrometry. Adv. Exp. Med. Biol. 443: 23-32. 9781339
68. Lambert L.A. Perri H. Halbrooks P.J. Mason A.B. 2005. Evolution of the transferrin family: conservation of residues associated with iron and anion binding. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 142 (2): 129-141. 10.1016/j.cbpb.2005.07.007 16111909
69. Langhorst J. Boone J. 2012. Fecal lactoferrin as a noninvasive biomarker in inflammatory bowel diseases. Drugs Today (Barc), 48 (2): 149-161. 22384454
70. Latorre D. Berlutti F. Valenti P. Gessani S. Puddu P. 2012. LF immunomodulatory strategies: mastering bacterial endotoxin. Biochem. Cell Biol.,. This issue. 10.1139/o11-059 22300429
71. Leader B. Baca Q.J. Golan D.E. 2008. Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug Discov. 7 (1): 21-39. 10.1038/nrd2399 18097458
72. Legrand D. 2011. Lactoferrin, a key molecule in immune and inflammatory processes. Biochem. Cell Biol.,. This issue. 10.1139/o11-056 22136726
73. Legrand D. Mazurier J. 2010. A critical review of the roles of host lactoferrin in immunity. Biometals, 23 (3): 365-376. 10.1007/s10534-010-9297-1 20143251
74. León-Sicairos N. Martínez-Pardo L. Sánchez- Hernández B. de la Garza M. Carrero C. 2012. Oral lactoferrin treatment resolves amoebic intracecal infection in C3H/HeJ mice. Biochem. Cell Biol. This issue. 10.1139/o2012-008 22452668
75. Levy O. 2004. Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. J. Leukoc. Biol. 76 (5): 909-925. 10.1189/jlb.0604320 15292276
76. Lönnerdal B. Jiang R. Du X. 2011. Bovine lactoferrin can be taken up by the human intestinal lactoferrin receptor and exert bioactivities. J. Pediatr. Gastroenterol. Nutr. 53 (6): 606-614. 21832946
77. Lupetti A. Brouwer C.P. Bogaards S.J. Welling M.M. de Heer E. Campa M. et al. 2007. Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection. J. Infect. Dis. 196 (9): 1416-1424. 10.1086/522427 17922408
78. Ma A.C. Kubes P. 2008. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J. Thromb. Haemost. 6 (3): 415-420. 10.1111/j.1538-7836.2007.02865.x 18088344
79. Malet A. Bournaud E. Lan A. Mikogami T. Tome D. Blais A. 2011. Bovine lactoferrin improves bone status of ovariectomized mice via immune function modulation. Bone, 48 (5): 1028-1035. 10.1016/j.bone.2011.02.002 21303707
80. Mariller C. Hardiville S. Hoedt E. Huvent I. Pina-Canseco S. Pierce A. 2012. delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor. Biochem. Cell Biol. This issue. 10.1139/o11-070 22320386
81. Masson P.L. Heremans J.F. Schonne E. 1969. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130 (3): 643-658. 10.1084/jem.130.3.643 4979954
82. Montreuil J. Tonnelat J. Mullet S. 1960. Pŕparation et proprít́s de la lactosid́rophiline (lactotransferrine) du lait de femme. Biochim. Biophys. Acta., 45: 413-421. 13772242
83. Morita Y. Matsuyama H. Serizawa A. Takeya T. Kawakami H. 2008. Identification of angiogenin as the osteoclastic bone resorption-inhibitory factor in bovine milk. Bone, 42 (2): 380-387. 10.1016/j.bone.2007.10.012 18055286
84. Naot D. Grey A. Reid I.R. Cornish J. 2005. Lactoferrin- A novel bone growth factor. Clin. Med. Res. 3 (2): 93-101. 10.3121/cmr.3.2.93 16012127
85. Nguyen L.T. Chau J.K. Perry N.A. de Boer L. Zaat S.A. Vogel H.J. 2010. Serum stabilities of short tryptophan-and arginine-rich antimicrobial peptide analogs. PLoS ONE, 5 (9): e12684. 10.1371/journal.pone.0012684 20844765
86. Nibbering P.H. Welling M.M. Paulusma-Annema A. Brouwer C.P. Lupetti A. Pauwels E.K. 2004. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J. Nucl. Med. 45 (2): 321-326. 14960656
87. Noinaj N. Easley N.C. Oke M. Mizuno N. Gumbart J. Boura E. et al. 2012. Structural basis for iron piracy by pathogenic Neisseria. Nature, 483 (7387): 53-58. 10.1038/nature10823 22327295
88. Ochoa T.J. Pezo A. Cruz K. Chea-Woo E. Cleary T.G. 2012. Clinical studies of lactoferrin in children. Biochem. Cell Biol.,. This issue. 22380791
89. Ortíz-Estrada G. Luna-Castro S. Piña-Vázquez C. Samaniego-Barrón L. León-Sicairos N. Serrano-Luna J. de la Garza M. 2012. Iron-saturated lactoferrin and pathogenic protozoa: could this protein be an iron source for their parasitic style of life? Future Microbiol. 7 (1): 149-164. 10.2217/fmb.11.140 22191452
90. Parikh P.M. Vaid A. Advani S.H. Digumarti R. Madhavan J. Nag S. et al. 2011. Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy. J. Clin. Oncol. 29 (31): 4129-4136. 10.1200/JCO.2010.34.4127 21969509
91. Park J.H. Park G.T. Cho I.H. Sim S.M. Yang J.M. Lee D.Y. 2011. An antimicrobial protein, lactoferrin exists in the sweat: proteomic analysis of sweat. Exp. Dermatol. 20 (4): 369-371. 10.1111/j.1600-0625.2010.01218.x 21366701
92. Richardson A. de Antueno R. Duncan R. Hoskin D.W. 2009. Intracellular delivery of bovine lactoferricin's antimicrobial core (RRWQWR) kills T-leukemia cells. Biochem. Biophys. Res. Commun. 388 (4): 736-741. 10.1016/j.bbrc.2009.08. 083 19699713
93. Rosenberg H.F. 2008. RNase A ribonucleases and host defense: an evolving story. J. Leukoc. Biol. 83 (5): 1079-1087. 18211964
94. Saponja J. Vogel H.J. 2011. Quadrupolar central transition and carbon-13 NMR competition studies of metal ion binding to ovotransferrin. Can. J. Chem. 89: 779-788. 10.1139/v11-019
95. Shcheglovitova O.N. Maksyanina E.V. Ionova I.I. Rustam'yan Y.L. Komolova G.S. 2003. Cow milk angiogenin induces cytokine production in human blood leukocytes. Bull. Exp. Biol. Med. 135 (2): 158-160. 10.1023/A:1023871931764 12802423
96. Shestakov A. Jenssen H. Nordstrom I. Eriksson K. 2012. Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice. Antiviral Res. 93 (3): 340-345. 10.1016/j.antiviral.2012.01.003 22269645
97. Siebert P.D. Huang B.C. 1997. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc. Natl. Acad. Sci. U.S.A. 94 (6): 2198-2203. 10.1073/pnas.94.6.2198 9122171
98. Singh P.K. Parsek M.R. Greenberg E.P. Welsh M.J. 2002. A component of innate immunity prevents bacterial biofilm development. Nature, 417 (6888): 552-555. 10.1038/417552a 12037568
99. Sohnle P.G. Hunter M.J. Hahn B. Chazin W.J. 2000. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J. Infect. Dis. 182 (4): 1272-1275. 10.1086/315810 10979933
100. Sorensen M. Sorensen S.P.L. 1939. The proteins in whey. C.R. Trav. Lab. Carlsberg, 23: 55-99.
101. Spadaro M. Caorsi C. Ceruti P. Varadhachary A. Forni G. Pericle F. Giovarelli M. 2008. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. FASEB J. 22 (8): 2747-2757. 10.1096/fj.07-098038 18364398
102. Stallmann H.P. Faber C. Bronckers A.L. de Blieck-Hogervorst J.M. Brouwer C.P. Amerongen A.V. Wuisman P.I. 2005. Histatin and lactoferrin derived peptides: antimicrobial properties and effects on mammalian cells. Peptides, 26 (12): 2355-2359. 10.1016/j.peptides.2005.05.014 15979203
103. Strøm M.B. Haug B.E. Rekdal O. Skar M.L. Stensen W. Svendsen J.S. 2002. Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. Biochem. Cell Biol. 80 (1): 65-74. 10.1139/o01-236 11908644
104. Tang L. Cui T. Wu J.J. Liu-Mares W. Huang N. Li J. 2010 a. A rice-derived recombinant human lactoferrin stimulates fibroblast proliferation, migration, and sustains cell survival. Wound Repair Regen. 18 (1): 123-131. 10.1111/j.1524-475X.2009.00563.x 20082685
105. Tang L. Wu J.J. Ma Q. Cui T. Andreopoulos F.M. Gil J. et al. 2010 b. Human lactoferrin stimulates skin keratinocyte function and wound re-epithelialization. Br. J. Dermatol. 163 (1): 38-47. 20222924
106. Tibble J.A. Bjarnason I. 2001. Non-invasive investigation of inflammatory bowel disease. World J. Gastroenterol. 7 (4): 460-465. 11819811
107. Tomita M. Wakabayashi H. Shin K. Yamauchi K. Yaeshima T. Iwatsuki K. 2009. Twenty-five years of research on bovine lactoferrin applications. Biochimie, 91 (1): 52-57. 18585434
108. Tsuda H. Kozu T. Iinuma G. Ohashi Y. Saito Y. Saito D. et al. 2010. Cancer prevention by bovine lactoferrin: from animal studies to human trial. Biometals, 23 (3): 399-409. 10.1007/s10534-010-9331-3 20407806
109. Valenti P. Antonini G. 2005. Lactoferrin: an important host defence against microbial and viral attack. Cell. Mol. Life Sci. 62 (22): 2576-2587. 10.1007/s00018-005-5372-0 16261253
110. van der Does A.M. Bogaards S.J. Jonk L. Wulferink M. Velders M.P. Nibbering P.H. 2010. The human lactoferrin-derived peptide hLF1-11 primes monocytes for an enhanced TLR-mediated immune response. Biometals, 23 (3): 493-505. 10.1007/s10534-010-9322-4 20238236
111. van der Does A.M. Joosten S.A. Vroomans E. Bogaards S.J. van Meijgaarden K.E. Ottenhoff T.H. et al. 2012 a. The antimicrobial peptide hLF1-11 drives monocyte-dendritic cell differentiation toward dendritic cells that promote antifungal responses and enhance Th17 polarization. J. Innate Immun., 4 (3): 284-292. 10.1159/000332941 22261275
112. van der Does A.M. Hensbergen P.J. Bogaards S.J. Cansoy M. Deelder A.M. van Leeuwen H.C. et al. 2012 b. The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity. J. Immunol. In press. 10.4049/jimmunol.1102777 22523385
113. van der Kraan M.I.A. Groenink J. Nazmi K. Veerman E.C.I. Bolscher J.G.M. Amerongen A.V.N. 2004. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides, 25 (2): 177-183. 10.1016/j.peptides. 2003.12.006 15062998
114. van der Kraan M.I.A. Nazmi K. Teeken A. Groenink J. van't Hof W. Veerman E.C.I. et al. 2005. Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part. Biol. Chem. 386 (2): 137-142. 10.1515/BC.2005.017 15843157
115. Voganatsi A. Panyutich A. Miyasaki K.T. Murthy R.K. 2001. Mechanism of extracellular release of human neutrophil calprotectin complex. J. Leukoc. Biol. 70 (1): 130-134. 11435495
116. Wakabayashi H. Yamauchi K. Takase M. 2006. Lactoferrin research, technology and applications. Int. Dairy J. 16: 1241-1251. 10.1016/j.idairyj. 2006.06.013
117. Ward P.P. Mendoza-Meneses M. Cunningham G.A. Conneely O.M. 2003. Iron status in mice carrying a targeted disruption of lactoferrin. Mol. Cell. Biol. 23 (1): 178-185. 10.1128/MCB.23.1.178-185.2003 12482971
118. Ward P.P. Paz E. Conneely O.M. 2005. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci. 62 (22): 2540-2548. 10.1007/s00018-005-5369-8 16261256
119. Welling M.M. Lupetti A. Balter H.S. Lanzzeri S. Souto B. Rey A.M. et al. 2001. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J. Nucl. Med. 42 (5): 788-794. 11337578
120. Yamniuk A.P. Burling H. Vogel H.J. 2009. Thermodynamic characterization of the interactions between the immunoregulatory proteins osteopontin and lactoferrin. Mol. Immunol. 46 (11-12): 2395-2402. 10.1016/j.molimm.2009.04.024 19477017
121. Yang Y. Kiss H. Kost-Alimova M. Kedra D. Fransson I. Seroussi E. et al. 1999. A 1-Mb PAC contig spanning the common eliminated region 1 (CER1) in microcell hybrid-derived SCID tumors. Genomics, 62 (2): 147-155. 10.1006/geno.1999.5952 10610706
122. Yen C.C. Shen C.J. Hsu W.H. Chang Y.H. Lin H.T. Chen H.L. Chen C.M. 2011. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection. Biometals, 24 (4): 585-594. 10.1007/s10534-011-9423-8 21327478